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ErythrocytesThe ﬂuorescent probe N-(BODIPY®-FL-propionyl)-neuraminosyl-GM1 (BODIPY-GM1) was used to detect lipid
rafts in living red blood cells (RBCs) membranes. The probe was detected with ﬂuorescence video microscopy
and was found to be uniformly distributed along plasma membrane at room temperature (23 °C). At 4 °C
some probe clearly phase-separated to yield detectable bright spots that were smaller than spatial resolution.
As measured by spectroﬂuorometry, in addition to a major ﬂuorescence peak caused by emissions from
monomers, the probe exhibited a red-shifted peak that is characteristic of a BODIPY ﬂuorophore at high local
concentrations, indicating that some probe had clustered. Red-shifted ﬂuorescence was the greatest at 4 °C,
intermediate at 23 °C, and the smallest at 37 °C. Treating the RBCs with methyl-β-cyclodextrin to remove
cholesterol eliminated the red-shifted peak. This strongly indicates that the presence of cholesterol was
essential for phase separation of the probe. Fluorometry experiments indicate that rafts exist at 23 °C and at
37 °C, even though the membrane appears to be uniform at the resolution of microscope. The distinct GM1
patches distributed over entire membrane of the erythrocytes were observed at both 23 °C and at 37 °C in
RBCs stained with Alexa FL 647 cholera toxin subunit B conjugate (CTB-A647 ). Based on both ﬂuorometry and
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Lipid composition is not uniform throughout the area of a cell
membrane and heterogeneity over a large spatial scale has been well
documented. It is known that lipid composition is different, for
example, in the apical and basolateral membranes of epithelial cells
[1]. More recently, lipid heterogeneity on the small, sub-micron
spatial scale has been the subject of intense research. Particular
attention has been focused on the question of whether cholesterol and
sphingolipids associate as segregated microdomains, known as lipid
rafts [2]. If proteins that must interact with other for biological
function preferentially partition into rafts, this would have implica-
tions for a number of processes. Signal transduction, for example, is
dependent on controlled protein interactions and if the proteins were
in rafts, they would automatically be in proximity [3–5].
The assertion that a speciﬁc protein resides in a raft is often based on
indirect evidence. A protein is a raft-associated candidate if it is found to
have accumulated in the portion of membrane not solubilized by non-
ionic detergents. These detergent-resistant membranes (DRMs) resultaftermembranes are dissolvedwith adetergent, usually TritonX-100, at
4 °C[6]. The DRMs are an appreciable fraction of themembranes and are
rich in cholesterol and sphingolipids as well as the DRM-associated
proteins [7–9]. However, there is no direct experimental evidence
that DRMs correspond to any membrane structures that existed before
the detergent treatment [10,11]. It is not certain that big and stable
rafts exist in biological membranes, particularly at physiological
temperatures. A bodyofwork has accumulated that favors the existence
of small (from several to hundred nanometers in radius) rafts in
plasma membranes at physiological temperatures [12–17], although
some experiments indicate otherwise [18–21]. It is possible that
some observed rafts are not due to preferential clustering, but rather
result from statistically random associations between cholesterol and
sphingolipids that lead to short-lived lipid domains. For rafts to serve as
an organizing structure in cellular processes, they need to be relatively
long-lived. Another complication for identifying rafts is evident from
computer modeling, which demonstrates that insertion of lipids into
the plasma membrane via exocytosis and retrieval via endocytosis
may promote occurrence of short-lived lipid domains via statistical
rather than preferential associations [22,23].
We tested whether long-lived rafts exist in living red blood cell
membranes. The presence of DRMs in RBCs membranes has been
documented before [6]. The RBC membrane has a few features that
signiﬁcantly simplify lipid raft detection: the RBCs do not contain
intracellular membrane compartments and the only membrane they
have is the plasma membranes; its lipid composition is stable for
months, and so there is no turnover of plasma membrane lipids.
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membrane cytoskeleton which precludes endocytosis,i.e., these cells
completely lack the endocytic/exocytic capability. The DRMs of RBCs
have been characterized with regard to properties such as their
abundance, the proteins they contain, and the extent of cholesterol
enrichment [24,25]. However, intact RBCs have not been systemat-
ically employed previously for lipid raft visualization.
The ganglioside GM1 is a convenient marker of lipid rafts [26]. It is
also greatly enriched in DRMs [27] and it preferentially accumulates
into liquid-ordered (Lo) domains that form in artiﬁcial bilayer
membranes [28,29]. In a previous study we attached BODIPY®-FL-
C3-residue to the residue of neuraminic acid of GM1 to yield a
ﬂuorescent lipid probe, BODIPY-GM1 and demonstrated that this
probe partitions into Lo phase of model bilayer lipid membranes [28].
In this report we used BODIPY-GM1 probe to directly observe lipid
rafts in living RBCs over the course of time by wide-ﬁeld ﬂuorescence
microscopy, and we correlate our observations with spectral shifts of
the probe, monitored by spectroﬂuorometry, which indicate the
probe has become concentrated in a lipid domain.
2. Materials and methods
2.1. Materials
Lipids 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), egg
sphingomyelin (egg-SM), ganglioside GM1 and cholesterol were
purchased from Avanti Polar Lipids, Inc. (Alabaster, AL). The ﬂuorescent
dye 4,4-diﬂuoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-
propionic acid (BODIPY®-FL-C3), BODIPY® FL C5-ganglioside GM1
(BODIPY® FL C5-GM1), Alexa FL 647 cholera toxin subunit B conjugate
and dark red ﬂuorescence FluoSpheres® (F8783, 0.02 μm, 660/680)
were obtained from Invitrogen (Eugene, OR). Methyl-β-cyclodextrin,
ganglioside GM1 and bovine serum albumin (BSA) was purchased from
Sigma-Aldrich (St. Louis, MO).
2.2. Synthesis of BODIPY-GM1 and preparation of BODIPY-GM1/GM1
micelles
N-(BODIPY-FL-propionyl)-neuraminosyl-GM1 (referred to as
BODIPY-GM1) was synthesized as described previously [28]. In
order to prepare micelles of GM1 with varying percentages of
BODIPY-GM1, labeled and unlabeled GM1 in chloroform-methanol
(2:1) were mixed at the desired ratios and the solvent was removed
by evaporation under vacuum for several hours. We kept the amount
of BODIPY-GM1 constant and varied the amount of unlabeled GM1 in
order to vary the percentage of the label within the micelles. In all
cases 2 ml of the solution (20 mM Tris–HCl, 1 mM Na2EDTA, pH 7.4)
was added to the dried GM1 at 4 °C. Fluorescencemeasurements were
performed at least an hour after adding the solution to the dried
gangliosides to ensure that equilibrium had been reached.
The optical density of BODIPY-GM1 was ~0.08, optimal for
ﬂuorescence measurements. For a molar extinction coefﬁcient of
80,000 [30] and a cuvette 1 cm wide, this yields ~1 μM (~2 μg/ml) of
the probe. Emission spectra collected for a 470 nm excitation were
corrected for small variations in probe quantity as determined from
the absorbance at 470 nm.
2.3. Preparation of liposomes
The liposomes were prepared by the extrusion technique [31]
using an extruder manufactured by Lipex Biomembranes Inc.
(Vancouver, Canada). Brieﬂy the dried lipid ﬁlm, containing 5 mol %
BODIPY-GM1, DOPC, egg-SM and cholesterol (each 30 mol %) was
hydrated to the necessary concentration by Tris–HCl buffer (pH 7.4)
containing 1 mM disodium salt of EDTA. The mixture was freeze-thawed ﬁve times and then passed 10 times through two polycar-
bonate ﬁlters (Nucleopore) with a pore size of 100 nm.
2.4. Labeling of RBCs
Human blood was freshly drawn from healthy volunteers. RBCs
were obtained by washing the blood twice in Ca2+, Mg2+ free
phosphate-buffered saline (PBS) at room temperature and re-
suspending as a 1% hematocrit in PBS. 15 μl of a 0.5 mM stock of
BODIPY-GM1 (or unlabeled GM1) in ethanol was added to 3 ml of
RBCs (yielding a ﬁnal probe concentration~2.5 μM) and incubated for
5–10 min at room temperature before washing the RBCs twice with
2.5% BSA in PBS to remove unincorporated probe. The BODIPY-GM1
formsmicelles and is taken up by RBCs to high concentrations over the
course of hours [32,33]. Incubation was limited to 5–10 min so that
the probe concentration in the RBCs would remain small. The
washings reduced the concentration of probe to well below the
critical micelle concentration of GM1[34], ensuring that micelles were
not bound to the RBCs. One half of the sample was then used
immediately for ﬂuorescence microscopy or ﬂuorescence spectrom-
etry. The other half was incubated at 4 °C for 30 min before using for
experiments. BODIPY® FL C5-GM1 (Invitrogen, USA) was used as a
control non-raft dye for RBCs labeling (same labeling method as for
BODIPY-GM1). To deplete RBCs of cholesterol, 3 mM methyl-β-
cyclodextrin was added to cells in a cuvette at the indicated
temperature and spectra were immediately gathered, with 20 s
between spectra.
CTB-A647 at 1 μg/ml at room temperature was added to RBCs for at
least 10 min. To wash out from the dyes RBCs were centrifuged at
3000 rpm for 1 min in an Eppendorf centrifuge 5415D. The RBC pellet
was washed twice by re-suspension/centrifugation cycle. Following
labeling/washing procedure, the erythrocytes were settled on pure
cover glasses for microscopy observation.
2.5. Fluorescence video microscopy and spectroﬂuorometry
Fluorescence microscopy was performed with an inverted ﬂuo-
rescence microscope (Nikon Eclipse TE200, Japan) equipped with an
oil immersion objective lens (Plan Apo 60X, NA 1.40) and a CCD
camera CoolSNAP HQ (Photometrics, AZ) set. Images were acquired
and processed by IPLabTM package (BioVision Technologies, PA). NIH
Image 1.63 software was used for image processing and analysis. The
temperature of the solution was maintained with a temperature
controller (20/20 Technology Inc., NC). Filter sets for BODIPY and
Alexa 647 were purchased from Chroma Technology Corp., VT.
2.6. Spectroﬂuorometry
LS-50B Fluorescence Spectrometer (PerkinElmer, MA) was used
for RBCs spectroﬂuorometry. RBCs labeled with BODIPY-GM1 were
placed in a thermostated quartz cuvette 1 cmwide, excited at 480 nm,
and the emission spectrum was measured and numerically smoothed
with FL WinLab™ software (PerkinElmer, MA). The BODIPY-GM1
ﬂuorescence emission spectra in micelles and liposomes were
recorded using a Fluorolog®-3 spectrometer (Jobin Yvon Inc., USA)
equipped with Glan-Thompson polarizers.
3. Results
3.1. BODIPY-GM1 can be used as a marker of lipid rafts in cells
Fluorescence emission of the labeled ganglioside BODIPY-GM1 as a
function of its density on the membrane surface behaved in the
manner expected for BODIPY. Probe density was varied by forming
mixed micelles that were composed of BODIPY-GM1 and GM1 at
different ratios (Fig. 1). When the probe was at low density (e.g., 1% of
Fig. 1. Emission of the BODIPY-GM1 probe in GM1-micelles at 4 °C. Micelles consisting
of the probe and GM1 were formed at the indicated ratios. The amount of the probe was
the same for all micelle preparations. (A) Lowmole fraction ratio of the probe. Only the
515 nm peak is prominent. (B) High mole fraction ratio of the probe. A broad red-
shifted peak, centered at 630 nm, appears. The lipid structure formula of BODIPY-GM1 is
shown in the insert.
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~515 nm, which is characteristic of the spectrum of monomeric
BODIPY (Fig. 1A). When the probe was dissolved in methanol, a
similar emission spectrum was obtained, in accord with the relatively
stable spectrum of BODIPY within different local environments [35].
For increased probe density, the high peak at 515 nm greatly
diminished and a broader one, centered at 630 nm, appeared
indicating BODIPY dimer formation. At ~20 mol% BODIPY-GM1, the
red-shifted ﬂuorescence had become prominent, but still less than
that of the 515 nm peak (Fig. 1B).
3.2. Rafts labeled by BODIPY-GM1 are visually observed, but only at low
temperature
We determined that domains into which BODIPY-GM1 was
concentrated could be microscopically detected. We viewed by
ﬂuorescence video microscopy whole RBCs labeled with the probe
and we quantiﬁed the green ﬂuorescence intensity centered at
515 nm. The cell is transparent enough for the ﬂuorescence of the
entire cell membrane, not just the surface closest to the objective, to
be collected. But the amount of membrane viewed at the rim of an
erythrocyte will obviously be greater than that viewed in the central
portion. At 23 °C, the ﬂuorescence was relatively uniform within the
non-rim area and here the intensities of the peaks were less than the
peaks at the rim (Fig. 2, left panels: bottom graph: cross-sectionbrightness histogram of intensity; middle: raw image; top: topo-
graphical histogram of brightness). This is indicative of a probe that
has not extensively segregated into domains. After lowering the
temperature to 4 °C, bright spots appeared (Fig. 2, central panels) and
the peaks of the brightness intensities in the non-rim region were
much higher than they had been in that area at 23 °C. Also at 4 °C, the
peaks of the intensities in the non-rim portions were comparable to
those at the rim. These observations suggest that the probe is
partitioning into discrete domains at the lower temperature. The
ﬂuorescence intensity in the red was less than that in the green (data
not shown). The presence of bright spots was reversible: they were
still observed 5 min after RBCs had been returned to room
temperature, but disappeared by 30 min.
We also labeled RBCs with commercial ﬂuorescent ganglioside
BODIPY® FL C5-GM1. This probe was uniformly distributed in RBCs at
37 °C, 23 °C and after cooling to 4 °C (Fig. 2, right panels). The
structures of both labels are shown in the insert of Fig. 2.
3.3. Domains rich in BODIPY-GM1 exist at physiological temperature as
suggested by spectroscopy
Because clustering of BODIPY-GM1 should lead to a red-shifted
emission, we used spectroﬂuorometry to measure the emission
spectrum of the probe in RBCs. The 515 nm green peakwas prominent
at 37 °C, at 23 °C, and at 4 °C (Fig. 3). At all three temperatures, a red-
shifted emission was also present. At 4 °C the red-shifted emission
was of somewhat larger amplitude than at 23 °C and 37 °C; at 37 °C,
the red-shifted ﬂuorescence extended out to 650 nm, a considerably
longer wavelength than appeared for high density of BODIPY-GM1 in
the absence of protein (Fig. 1B). This anomalous red shift, combined
with the fact that BODIPY-GM1 does not phase separate with
cholesterol or with itself in bilayer membranes if GM1 is the only
sphingolipid [28], makes it unlikely that the BODIPY-GM1 had self-
aggregated within the RBCs membranes. The red-shifted emission
therefore indicates that at all temperatures a fraction of the BODIPY-
GM1 had segregated into domains, but the domains were too small to
be detected microscopically at the higher temperatures. BODIPY-GM1
forms ﬂuorescent dimers at high local concentration. BODIPY dimers
have the emission maximum at 630 nm [34]. In contrast the emission
spectra of BODIPY® FL C5-GM1 in RBCs did not reveal any red shift at
all three temperatures (Fig. 3).
We removed cholesterol from the RBCs membranes at 4 °C to
further test whether the red-shifted ﬂuorescence was reporting rafts:
methyl-β-cyclodextrin was added to BODIPY-GM1-labeled RBCs to
extract the membrane cholesterol. Within minutes of the addition of
methyl-β-cyclodextrin, the green emission at 515 nm increased. Over
a time course of several minutes, there was also a decrease in the red-
shifted emission (Fig. 4, lines 1–4; line 1,spectrum before methyl-β-
cyclodextrin addition; lines 2, 3 and 4, measured each 2 min).
3.4. BODIPY-GM1 incorporated in liposomes formed from lipid raft
mixture reveals liquid-ordered phase formation
As a control, we performed the experiments with liposomes
formed from rafts lipid mixture (DOPC/egg-SM/cholesterol; 1:1:1+
5 mol% BODIPY-GM1). For this lipid mixture the liquid-ordered
domains were observed by ﬂuorescence microscopy only at the
temperatures below than 50 °C (main phase transition temperature
Tm of egg-SM) [28]. At this temperature BODIPY-GM1 randomly
distributes through the entire membrane. If the temperature is
lowered to 25 °C, BODIPY-GM1 will preferentially partitions into
newly formed Lo phase. Then BODIPY ﬂuorescence at 630 nm should
increase because of the higher probe concentration inside the
domains. We measured the BODIPY emission spectra of the raft
liposomes at 50 °C and 4 °C (Fig. 5). The low red-shifted emission was
already present at 50 °C, but it distinctly increased at 4 °C (the
Fig. 2. Visualization of the RBCs membrane domains enriched in BODIPY-GM1 as observed by ﬂuorescence microscopy. Top: topographical histogram of brightness. Middle: raw
image. Bottom: brightness histogram of cross-section (the white line at raw image). Punctate bright spots are apparent at 4 °C, but not at 23 °C (for BODIPY-GM1). RBCs labeled by
BODIPY® FL C5-GM1 have uniform probe distribution at all temperatures (right, 4 °C). The structures of BODIPY-GM1 and BODIPY® FL C5-GM1 are shown in the insert.
Fig. 3. Fluorescence emission spectra of BODIPY-GM1 and BODIPY® FL C5-GM1
incorporated into RBCs. Spectra are shown for 4 °C, 23 °C, and 37 °C, all normalized
to the monomer peak at the 515 nm. A broad red-shifted peak is more prominent for
lower temperature for BODIPY-GM1 but not for BODIPY® FL C5-GM1 (the results are
shown only for 4 °C).
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50 °C). The effect was reversed by the temperature raise back to 50 °C
(data not shown).
3.5. CTB-A647 treatment of intact erythrocytes reveals GM1 spots at
physiological temperatures
We used CTB-A647 as an alternative tool to visualize the
localization of endogenous GM1 on the plasma membrane of living
erythrocytes. Freshly isolated RBCs were labeled by CTB-A647. Time-
lapse microscopy revealed multiple GM1-enriched patches on the
erythrocyte surface at room temperature (Fig. 6, Movie 1). These
patches were randomly distributed on ﬂat membranes of discoid cells
andmost of them underwent fast lateral motionwith velocity of about
0.5 μm/s (Fig. 7, Movie 2). To obtain brighter patch images we used
1.5 s exposure times and the maximum power of the excitation light.
At that exposure times some patches appeared “fuzzy” because of the
fast patch movement (Movie 2). Time-lapse imaging did not reveal
any stable coalescence or self-aggregation of these patches during the
observation time (Movie 1). The average velocity of the brightest
Fig. 4. Fluorescence emission spectra of BODIPY-GM1 labeled RBCs after methyl-β-
cyclodextrin treatment. Line 1,spectrum before methyl-β-cyclodextrin addition; lines
2, 3 and 4,measured each 2 min thereafter. Spectra are normalized to the monomer
peak at the 515 nm.
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Movie 2). At 37 °C these patches were still observed but their fast
movement did not allow us to get sharp images (data not shown).
We also applied CTB-A647 to erythrocytes pre-labeled with our
probe BODIPY-GM1. The living erythrocytes were labeled with
BODIPY-GM1 according to standard labeling procedure and cooled
to 4 °C to induce visible domains. CTB-A647 was added at 4 °C. Then
RBCs were washed twice and transferred to the cooled microscope
stage for immediate recording in the red and the green channels. The
BODIPY-GM1 colocalized with CTB-A647 only in bright patches
(Fig. 8B, C), indicating that the limited sensitivity does not allow for
direct observation of small rafts labeled only by the lipid probe. We
also found that CTB-A647 binds to the BODIPY-GM1-labeled RBCs
stronger than to the non-labeled ones (Fig. 8B, Table 1). To
corroborate the idea that CTB-A647 does in fact bind to our probe
BODIPY-GM1, we incubated RBCs with non-labeled GM1 at the same
experimental conditions (2.5 μM of GM1, 5 min incubation). We
observed that GM1-treated RBCs also bound more CTB-A647 than
control RBCs (Table 1).Fig. 5. Fluorescence emission spectra of BODIPY-GM1 labeled raft liposomes. Spectra of
raft liposomes (DOPC/egg-SM/cholesterol, 1:1:1) with 5 mol% of the probe at 50 °C and
4 °C.In summary both ﬂuorometry and ﬂuorescence microscopy
showed that BODIPY-GM1 segregates into domains at low tempera-
ture. Fluorometry data indicated that the probe preferentially
partitioned into these domains at all three experimental tempera-
tures, and the spectral changes caused by addition of methyl-β-
cyclodextrin suggested that these domains are lipid rafts. Time-lapse
microscopy of erythrocytes labeled with CTB-A647 revealed that
these domains are highly mobile and can diffuse with 0.3–0.5 μm/s
velocity over the entire erythrocyte surface.
4. Discussion
4.1. Evidence that rafts exist at elevated temperatures
Fluorometry indicates that RBCs contain rafts at 23 °C and 37 °C,
even though the membrane appears uniform by ﬂuorescence
microscopy. It was already known, as determined by ﬂuorescence
resonance energy transfer, that a lipid bilayer membrane can
appear visually uniform yet contain tiny domains [36]. With
BODIPY-GM1 we visually detected rafts in RBCs at 4 °C but not at
the higher temperatures. Domains with sizes comparable to micro-
scope resolution have been observed in RBCs at room temperature
(20 °C) using the ﬂuorescent probe Laurdan (2-dimethylamino-6-
lauroylnaphthatlene); these domains were liquid-ordered (Lo) and
therefore could have been cholesterol–sphingolipid rafts [37].
Domains in RBCs have also been visually observed at room
temperature in intact erythrocytes with the phospholipid probes
NBD–phosphatidylcholine or NBD-phosphatidylethanolamine, but
these probes should not mark rafts because NBD ﬂuorophore was
attached to the fatty acid residue. Domains did not form in vesicles
made from extracted RBCs lipids [38]. This indicates that the resulting
lipid mixture lacks the high concentration of sphingomyelin and
cholesterol found in the outer leaﬂet of native erythrocyte membrane.
The possibility that the lipid asymmetry plays a key role in the
formation of such domains cannot be excluded. Recently Tyteca
et al. [39] have demonstrated that ﬂuorescent sphingomyelin (SM)
analogs spontaneously cluster at the outer leaﬂet into micrometric
domains in contrast with homogeneous labeling by DiIC18 and
TMA-DPH. With regard to lipid probes, attaching ﬂuorophores to
sphingolipid terminal side chain have perturbed the molecules so
much that they do not preferentially partition into rafts of lipid
membranes [28,40,41].Most of thehead-labeledﬂuorescentprobes also
prefer the Ld phase over the more ordered Lo phase in the ternary
mixtures of DOPC/DPPC/cholesterol [42]. NBD-DPPE is one of the rare
ﬂuorescent probes that has been reported to preferentially partition
into Lo domains in several model membrane systems [29,42–44].
DiIC18, a ﬂuorescent probe with longer side chains, showed no
preference for either the Ld or Lo phase [42].
Cholera toxin B subunit binds GM1, a major raft marker in
biological membranes. This ligand is pentavalent and previously it
has been shown that it induces cholesterol-dependent micrometer-
scale coalescence of GM1 domains on the surface of plasmamembrane
spheres (PMS) [45,46]. There is no contact between from the
membrane and the cell cytoskeleton in PMS. They are also not
effected by endocytic/exocytic lipid turnover. In this model system
large-scale domains can be induced by CTB-mediated clustering of
endogenous GM1 at 37 °C. The big rafts appearance is attributed to the
CTB-induced coalescence of pre-existing nanometer-scale rafts. The
authors explained the absence of micrometer-scale domains in native
cell membranes by the “lack of raft-based connectivity between the
gangliosides and other elements of plasma membrane.”
CTB can clusters only up to ﬁve single GM1 molecules even though
it is a pentameric subunit [47]. To force raft coalescence in native cell
membranes the method of secondary crosslinking has been used. In
this method GM1 bound CTB is cross-linked by anti-CTB antibodies
(Ab) to induce big micron-size patches in human monocytes and
Fig. 6. The distribution of endogenous GM1 in live human erythrocytes. RBCs were incubated with Alexa 647-labeled cholera toxin subunit B, washed twice and observed under
microscope. Time-lapse images were recorded at 100% mercury lamp power and 1.5 s exposure time (see also Movie 1). Scale bar: 5 μm.
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sufﬁcient to induce large-scale changes on the cell membrane on its
own, without help of the secondary Ab cross-linking. The dissociation
constant for the CTB-GM1 complex is 4.6×10−12 M [49] so the excess
of CTB applied to the cell surface should bind all available GM1
molecules. We hypothesize that CTB applied to the live RBCs binds
both free non-raft GM1 and raft-associated GM1 thus creating the real-
time surface density map of endogenous GM1. CTB concentration
should be higher (brighter in ﬂuorescence) inside these domains since
lipid rafts are enriched with GM1. Further raft coalescence needs the
secondary cross-linking by antibodies [16]. As we excluded this step,
we believe that after CTB treatment we observed the pre-existing
erythrocyte rafts.
The question is why we did not observe these GM1 patches at
physiological temperatures when we use BODIPY-GM1 probe, but
clearly detect them with CTB-A647? It has been shown that the lipid
rafts (50–60 nm in diameter) diffuse as small entities in the plasma
membrane of mammalian cells [12]. It has been further estimated that
such nano-raft contains some 3500 lipid molecules. Another group
showed that raft-related domains could be even larger: 200 nm in
diameter [13]. The existence of nanoscale (b5 nm and b20 nm
diameter) cholesterol-sensitive clusters in live cell membranes was
also reported [17,50]. Thus, the lipid rafts discovered in cells are below
the resolution of conventional ﬂuorescence microscopy (300 nm).
The incorporation of exogenous gangliosides into the cell plasma
membrane is well established phenomenon. However the extent of
incorporation may be limited and is reported to depend on the cell
type [51]. Ackerman et al. [51] indicated that a ﬁnite number of sites
available to bind exogenous ganglioside GM1 exists in the human
erythrocyte membrane. In this study the human erythrocytes were
incubated with exogenous GM1 (concentration range 0.1–0.5 mg/ml,
30 min incubation at 37 °C) followed by ﬁxation and cholera toxin
treatment. The average ratio of ﬁnal endogenous/exogenous GM1 was
approximately 1:1,i.e., even at high concentrations of exogenous GM1
human red blood cells could to uptake only 1 molecule of exogenous
GM1 per 1 molecule of endogenous GM1. Based on these data and ourFig. 7. The trajectory of an individual GM1 patch on the surface of a live erythrocyte.
Time-lapse images were recorded at 100% mercury lamp power and 1.5 s exposure
time. Complete trajectory of moving GM1 patch (arrow) is shown on the right image
(the domain traveled 3.5 μm for 7.5 s). One domain was immobile during the
observation time (arrowhead). Scale bar: 5 μm.observations we hypothesize that BODIPY-GM1 incorporates into
entire erythrocyte membrane evenly across its surface and then
equilibrates with the pre-existing non-uniformly distributed endog-
enous GM1. Then BODIPY-GM1 should partition in these sub-micron
pre-existing rafts; it is unlikely, however, that the probe can displace
all endogenous GM1 from the rafts. Let us assume a pre-existing
erythrocyte raft contains 100 molecules of endogenous GM1. The
exogenous BODIPY-GM1 will enter the membrane approximately at
1:1 endogenous/exogenous ratio (based on the fact that a limited
number of sites available to bind exogenous ganglioside GM1 exist in
the human erythrocyte membrane—reported by [51]; see also
Table 1). Therefore, after the equilibrium BODIPY-GM1 can displace
only 50 of endogenous intra-raft GM1 molecules. The local concen-
tration of the probe inside the pre-existing rafts will be sufﬁciently
high to form BODIPY dimers that are detected by the spectroscopy
method revealing non-uniform probe distribution. The limited
sensitivity of ﬂuorescence microscopy does not allow detection of
50 BODIPY-GM1 molecules in individual raft at room temperature.
Nevertheless the small GM1 patches were observed after labeling
with CTB-A647 at physiological temperatures (Fig. 6). The distinct
GM1 patches in the membranes of human erythrocytes have been
described before [48,52]. In these studies the GM1 patches in RBC
membrane were induced by the secondary cross-linking technique:
erythrocytes were incubated with Alexa 555-conjugated CTB and,
following two washes, the cells were incubated with anti-CTB
antibodies and ﬁxed. This method usually resulted in the formation
of 40–60 GM1 patches evenly distributed over the membrane of
discoid erythrocytes. However the DRM-associated proteins were
only partially colocalized with GM1 patches.
To avoid any artifacts induced by the secondary cross-linking and
ﬁxatives we labeled RBCs by CTB alone. We used a CTB-A647 lot with
DOL=5 (the degree of labeling, 5 mol of the dye per mole of the B
subunit pentamer). Alexa Fluor 647 has a far red ﬂuorescence
emission with maximum at 668 nm (Ex/Em: 650/668 nm) and a
very high extinction coefﬁcient of 270,000 (for comparison Alexa
Fluor 555 molar extinction coefﬁcient is 155,000 and that of BODIPY
FL is 80,000). We also chose Alexa 647 because of its negligible
bleedthrough with BODIPY FL. Though human vision has low
sensitivity to light beyond 650 nm, the cooled CCD camera has almost
equivalent sensitivity in 500–700 nm range. The raft containing 100
molecules of endogenous GM1 molecules could bind up to 100 CTB
subunits because the reported binding molar ratio generally reported
is 1:1 (CTB:GM1) [53]. This will be equivalent to 500 molecules of
Alexa 647 dye per single lipid raft. Our hardware allows detection of a
single ﬂuorescent bead 20 nm in diameter (F8783, Invitrogen, dark
red ﬂuorescence with Ex/Em: 660/680 nm) at the same observation
conditions (data not shown). These ﬂuorescent beads contain
approximately 200 molecules of ﬂuorophore (information provided
by Invitrogen for yellow–green beads 20 nm in diameter). So,
altogether, we should have at least 10 times brighter raft labeling
with CTB-A647 than with BODIPY-GM1. Double-labeling of RBCs with
BODIPY-GM1 and CTB-A647 revealed that these two rafts markers
Fig. 8. The RBCs costained with BODIPY-GM1 and CTB-A647. Live erythrocytes were labeled with BODIPY-GM1 according standard labeling procedure and cooled to 4 °C to induce
visible domains. CTB-A647 was added at 4 °C; RBCs were washed twice and transferred to the cooled microscope stage for immediate recording in the red and the green channels.
(A) Phase contrast image of RBCs. (B) CTB-A647 ﬂuorescence (red channel). (C) BODIPY-GM1 ﬂuorescence (green channel). BODIPY-GM1 colocalized with CTB-A647 only in
brightest patches (arrows in B and C). Limited sensitivity did not allow to directly observe the smaller rafts seen only with CTB-A647. Scale bar: 5 μm.
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observations suggest that the number of BODIPY-GM1 molecules in
small rafts is not enough to resolve them with conventional
ﬂuorescence microscopy. Our ﬁndings indicate that low temperature
promotes the growth of pre-existing small rafts. These growing
domains concentrate more BODIPY-GM1 and at certain size come
within our detection limit.
4.2. Rafts are large in bilayer membranes, small in RBCs
RBC membranes remain ﬂuid even when temperature is lowered
to −5 °C[54]. It is well known that increasing concentrations of
cholesterol reduces gel-to-ﬂuid phase transitions and abolishes
them at ~20–25 mol% [55]. RBCs membranes contain 30–50 mol%
cholesterol [56,57], and it is therefore likely that the rafts, even at 4 °C,
are not in a solid phase, but rather are in a liquid-ordered phase, as has
been demonstrated for bilayer membranes [28,29]. In artiﬁcial lipid
bilayer membranes, small rafts that form merge to reach diameters of
tens of microns [28,29]. In RBCs, the rafts labeled by BODIPY-GM1 do
not becomemicroscopically detectable at physiological temperatures.
However, we have demonstrated that they do exist at these
temperatures and that they are mobile objects (Fig. 6). Either small
rafts do not merge or if they do, the enlarged rafts are not stable and
their lipids dissolve into the bulk of the membrane. Whatever the
speciﬁc mechanism, rafts stay small in biological membranes at
normal physiological conditions.
Methyl-β-cyclodextrin (3 mM)was added to BODIPY-GM1-labeled
RBCs to remove the membrane cholesterol. We observed both the
increase in emission at 515 nm (data not shown) and the decrease at
630 nm (Fig. 4). This indicates that as the cholesterol was removed,
BODIPY-GM1 that had been laterally segregated in the membrane
became dispersed. However, the increase in emission at 515 nm is
not a reliable indicator for BODIPY-GM1 spread within an intact RBCs
upon removing cholesterol: the treatment of RBCs with methyl-β-
cyclodextrin is known to cause a fraction of RBCs to hemolyze [58,59].
The change in scattering of light caused by hemolysis could have
contributed to the increase in emission at 515 nm. But hemolysisTable 1
Effect of exogenous BODIPY-GM1 and GM1 on CTB-A647 surface labeling of living
human red blood cells.
Sample Mean I647, a.u.⁎
1. Un-treated RBCs 5±1
2. RBCs incubated with BODIPY-GM1 (5 min, 2.5 μM) 12±2
3. RBCs incubated with GM1 (5 min, 2.5 μM) 23±4
⁎ Mean intensity of CTB-A647 ﬂuorescence in region of interest (ROI) of single
erythrocyte. ROI diameter is 5 μm (to exclude the rim of an erythrocyte). For each
number at least 25 cells were analyzed.would not account for the decreased emission at 630 nm and indeed
this decrease strongly suggests that segregation of the BODIPY-GM1
probe required a high concentration of cholesterol in the membrane
that the probe segregated into cholesterol-sphingolipid rafts rather
than self-segregated, and that raft extent was greater with lowering of
temperature.
It has recently been suggested that DRMs in RBCs could be
anchored to the spectrin skeleton of human erythrocytes via
electrostatic interactions [8]. The disruption of these pre-existing
interactions between the lipid rafts and RBC cytoskeleton by the
simultaneous increase in pH and ionic strength of the medium would
result in the preparation of DRMs that are free of cytoskeletal
components and are strongly enriched in the classical raft marker
proteins and lipids (e.g., stomatin, ﬂotillin-1, and ﬂotillin-2, choles-
terol and GM1[8,60,61]. We showed here that the majority of GM1-
enriched patches in the erythrocyte membrane are mobile and move
with velocity range 0.3–0.5 μm/s at the room temperature (Figs. 6–7,
Movies 1 and 2). It is unlikely that these structures tightly interact
with spectrin submembrane cytoskeleton of erythrocytes. However,
our data do not exclude the possibility that some big rafts anchor to
RBC cytoskeleton at 4 °C.
4.3. Raft formation may continue as temperature is progressively lowered
Glycosylphosphatidylinositol (GPI)-anchored proteins associate
with DRMs of membranes in general [2,62] and RBCs in particular [25]
and an appropriately engineered GPI-ﬂuorescent probe (e.g., GPI-
linked green ﬂuorescent protein) should be a convenient marker for
rafts. But whereas endogenous GPI-anchored proteins associate with
DRMs, adding GPI-linked proteins to solution to artiﬁcially incorpo-
rate them into RBCs does not lead to DRM association [63]. With
regard to lipid probes, attaching ﬂuorophores to sphingolipids or to
the terminal side chain of cholesterol have perturbed the molecules
so much that they do not preferentially partition into rafts of lipid
membranes [28,40,41]. The ﬂuorescent probe Laurdan reports the
existence of liquid-ordered domains, but two-photon ﬂuorescence
microscopy is required to follow it [37]. Dehydroergosterol serves
as an analog for many of cholesterol's properties and is naturally
ﬂuorescent. But it ﬂuoresces in the ultraviolet (UV), and this
necessitates the use of a microscope that allows for high transmit-
tance in the UV in conjunction with a UV-sensitive camera [64].
Attaching BODIPY to the headgroup of GM1 to yield BODIPY-GM1
(Fig. 2, insert) provides a good raft probe that can be detected by
conventional ﬂuorescence microscopy [65]. Moving the BODIPY label
into the lipid tail of GM1 (Fig. 2, insert) makes the probe insensitive to
the presence of rafts as evidenced by both spectroscopy and
microscopy (Fig. 2 and 3). BODIPY-GM1 clearly marks rafts in artiﬁcial
lipid bilayer membranes [28] and in the membranes of RBCs as was
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inferred from the CTB-A647 and BODIPY-GM1 probes and those found
in other systems that have been measured by sophisticated particle
tracking methods to have a radius of only 30 nm [12] remains to be
determined.
The relation of cell rafts andDRMsusually isolated in cold (4 °C) non-
ionic detergents suchasTritonX-100wasalwaysquestionable [6,10,66].
The recent study showed that DRMs could be prepared from intact
erythrocytes at 37 °C[67]. However, authors reported that in contrast to
the4 °C results raft-associatedproteinsﬂotillin-2 and stomatinwere not
resistant to Triton X-100 treatment at the physiological temperatures.
Then there is a question: Are the DRMs just a product of coalescence/
fusion of small pre-existing rafts or the low temperature promotes the
DRMs formation? Indeed, if the DRMs are formed solely by the low
temperature, it should be classiﬁed as an “artifact.” On the other hand
the coalescence of small pre-existing rafts into big domains induced by
the low temperature could be helpful for isolation of DRMs.
The novel probe BODIPY-GM1 incorporates into the biological
membranes and serves as a sensitive indicator of endogenous raft
dynamics. Exogenous gangliosides readily transfer from micelles into
RBCs membranes. The rate of the incorporation is probably determined
by the rate ofmonomer entry into the solution from themicelles [51]. In
our study RBCs were readily labeled with BODIPY-GM1 or plain GM1 by
mixing the cells with BODIPY-GM1 (or non-labeled GM1) micelles. The
GM1 is known toaccumulate greatlywithin theDRMs for cells in general
[27]. We previously showed that BODIPY-GM1 is relatively abundant in
liquid-ordered cholesterol–sphingomyelin domains in artiﬁcial bilayer
membranes [28]. Here we used it to probe for the existence of lipid rafts
in intact RBCs membranes.
Exogenous GM1 incorporated into membranes distributes similar
to endogenous ganglioside GM1i.e., it is enriched lipid rafts. At high
local concentration two BODIPY groups are stacked on top of each
other and form a dimer that emits light as a broad band centered at
about 630 nm in addition to the normal green emission (peak at
515 nm) [34,68]. It was shown earlier that ﬂuorescent derivatives of
ganglioside GM1 where the polar ﬂuorophore was chemically
attached to the sialic acid residue still function as receptors for
cholera toxin [69–71]. Our ﬁndings indicate that CTB interacts with
BODIPY-GM1 similar to the intact GM1 (Table 1). All these properties
of this new probe could be very useful in future membrane studies.
Data from micelle experiments suggest that the local concentra-
tion of BODIPY-GM1 should be higher than 20 mol% to get the
signiﬁcant 630 nm band (Fig. 1B). This pattern is the same as the one
ﬁrstly shown for a BODIPY-labeled ceramide [68]. The spectral shift to
longer wavelengths with increasing probe density could be due to
either excimer formation [35] or resonance energy transfer from
monomers to dimers of BODIPY that form at high density [34]. The
appearance of a red-shifted emission would indicate that the probes
had laterally segregated into high local density regions.
Spectroscopy data revealed that BODIPY-GM1 incorporated into
the RBCs at low concentrations displays the red shift already at the
physiological temperatures (Fig. 3). We attributed these results to the
incorporation of the probe into the pre-existing lipid domains with
high endogenous ganglioside GM1 concentration. We observed these
domains with CTB-A647 (Figs. 6–7). The cooling of RBCs to 23 °C and
4 °C substantially increased the amplitude of 630 nm peak. This result
cannot be explained only by the coalescence of the pre-existing rafts.
The BODIPY-GM1 was distributed non-uniformly before cooling:
partially it was in the raft domains (it emits both green and red
ﬂuorescence)while another part was in the non-raft membrane phase
(it emits only green ﬂuorescence). If cooling to 4 °C induced only raft
coalescence but does not produce additional raft phase it should not
change intra-raft GM1 (and BODIPY-GM1) raft partition. So, we
explained the increase in 630 nm peak by formation of new rafts (or
by growing of the pre-existing rafts) and by partitioning of free non-
raft BODIPY-GM1 into these newly formed rafts.On general principles, phase separations should occur only below
phase coexistence temperatures determined by the precise cholesterol–
sphingolipid–phospholipid compositions. Phase separations of raft
formationwill depend on themelting temperatures of the sphingolipids
and phospholipid, which are molecularly heterogeneous. For example,
the sphingomyelins of RBCs have melting temperatures between 51 °C
(for a 22:0 acyl chain) and 27 °C (a 24:1 chain) [72,73]. For cholesterol
and sphingomyelin to pack well together, as is necessary for phase
separation, temperature must be below the sphingomyelin melting
temperature (the amount below depends on the molar fraction of the
sphingomyelin). As temperature is progressively lowered, the acyl
chainsofmore sphingomyelin species should becomeorderedandmore
cholesterol-dependent phase separations should occur. In living RBCs
the weakly cooperative phase transitions at 14 °C and at 34 °C were
shown by Fourier transform infrared spectroscopy (FTIR) [74]. Multiple,
sharp membrane phase transitions were observed in RBCs stored at
4 °C for 5 days, which indicated phase separation of the membrane
lipids. The authors reported that the lipid probe 1,1'-dioctadecyl-
3,3,3',3-tetramethyl-indocarbocyanine perchlorate (diI-C18) remained
homogeneously distributed in the erythrocyte membrane during cold
storage and concluded that lipid domains were below the resolution
limit of the microscope. However, a recent study showed that the
ﬂuorescent probe, DiI-C18, showed no preference for either the Ld or
Lo phase [42].
Heterogeneity in sphingolipid species may therefore account for
the greater extent of rafts that occurs at lower temperature. The
progressive increase in the red shift emission of BODIPY-GM1 in RBCs
at 4 °C could be explained by the existence of low melting lipids
(SM and PC) that have Tm between 4 °C and 37 °C. Our experiments
with liposomes formed from raft lipid mixture showed that liquid-
ordered phase also appeared below Tm of the main raft component
sphingomyelin (Fig. 5). We observed it as an increase in BODIPY-GM1
ﬂuorescence intensity at 630 nm (Fig. 5). The effect of liposome
cooling on BODIPY-GM1 red shift was reproducible but not so strong
(+15% of ﬂuorescence intensity at 630 nm) as we were expecting
based on bilayer lipid membranes experiments [28]. It has been
emphasized that the continuous high-intensity illumination of giant
unilamellar vesicles (GUVs) labeled with ﬂuorescent lipid analogs
induces micron-size domain formation [75]. The large domains
observed in GUVs were the result of merger of visually unobservable
small domains. However, the authors reported that “the efforts
to detect light-induced domains in an intensely illuminated cuvet
have failed because of the difﬁculty of achieving the needed light
intensity.” So we cannot exclude the possibility that the cooling
of raft liposomes from 50 °C to 4 °C induces the formation of only
tiny lipid domains (nano-rafts) [76–78]. These small nanoscopic
domains can be formed and remain small, without enlarging. The
nanoscopic domain merging could be induced by light [44,75] or
by the lateralmembrane tension [78]. The BODIPY-GM1will partition
into these domains resulting in the red peak at 630 nm to grow
(Fig. 5). In the absence of forces that induce small rafts merging
(high intensity of light and/or membrane tension) the number
and/or size of formed lipid rafts could be limited in 100-nm-diameter
liposomes.
Why are the studies of RBCs lipid rafts and raft dynamics
important? Early study by Gratzer and coworkers [79] has reported
that the lowering erythrocyte's cholesterol decrease the malarial
infection. But the underlying reason for these ﬁndings has not been
found. Samuel and coworkers have reported that depletion of raft
cholesterol (which constitutes up to 10% of total erythrocyte
cholesterol) not only disrupts all protein association in rafts but also
abrogates malarial infection into the red cells [25]. Deﬁnitely, a
disruption of erythrocyte rafts is detrimental to malarial infection
suggesting that these lipid/protein domains are essential for the
parasitization of the RBCs. However, detailed mechanisms of the
utilization of RBCs rafts in malarial infection are still unknown.
1938 I. Mikhalyov, A. Samsonov / Biochimica et Biophysica Acta 1808 (2011) 1930–1939The entry of individual merozoite in erythrocyte is very rapid
process and it complete on average 27.6 s after primary contact of
parasite with host RBC [80]. Our ﬁndings indicate that lipid domains in
living RBCs are highlymobile structures and they can diffuse on a time
scale of 30 s over the entire erythrocyte surface. Whether the pre-
existing erythrocyte raft segregation by merozoite is necessarily to
initiate the membrane invagination and parasite invasion remains to
shown. We believe that our probe BODIPY-GM1 could be useful tool
for mechanistic studies of malaria parasite invasion in RBCs.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamem.2011.04.002.
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